Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Tadahiro Shoji"'
Autor:
Tadahiro Shoji, Ryosuke Takeshita, Tatsunori Saito, Takeshi Aida, Shunichi Sasou, Tsukasa Baba
Publikováno v:
Journal of Ovarian Research, Vol 13, Iss 1, Pp 1-5 (2020)
Abstract Background Primary ovarian signet-ring cell carcinoma is extremely rare, with only five recent case reports. Almost all reported cases of ovarian signet-ring cell carcinoma have been treated with TC therapy and none have reported regarding t
Externí odkaz:
https://doaj.org/article/d2c7a0ddb57f4e99bdc11b9ff117294e
Autor:
Satoshi Takeuchi, Masahiro Kagabu, Tadahiro Shoji, Yukari Nitta, Toru Sugiyama, Junya Sato, Yusuke Nakamura
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
We had conducted phase 1/2 studies of cancer vaccination therapy using neo-tumor antigens in patients with refractory/persistent cervical cancer (CC) and ovarian cancer (OC) to assess the feasibility and efficacy. Enrollees must be refractory/persist
Externí odkaz:
https://doaj.org/article/e6c3f39f6e5d435593a55f65e7673ead
Autor:
Tadahiro Shoji, Shinichi Komiyama, Junzo Kigawa, Hiroshi Tanabe, Kazuyoshi Kato, Hiroaki Itamochi, Hiroyuki Fujiwara, Shoji Kamiura, Tetsutaro Hamano, Toru Sugiyama, for the Japanese Gynecologic Oncology Group
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background We present the study rationale and design of the JGOG3023 study, an open-label, parallel-arm, randomized, phase II trial that aimed to assess the efficacy and safety of chemotherapy with or without bevacizumab in patients with pla
Externí odkaz:
https://doaj.org/article/50718e1a031a4176b1c4e284b599417a
Autor:
Tadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba
Publikováno v:
Medicina, Vol 57, Iss 5, p 501 (2021)
The incidence of ovarian cancer, which has had a poor prognosis, is increasing annually. Currently, the prognosis is expected to improve with the use of molecular-targeted drugs and immune checkpoint inhibitors as maintenance therapies after the firs
Externí odkaz:
https://doaj.org/article/f3cf1dacd500487098a325f17ece4309
Autor:
Masahiro Kagabu, Takayuki Nagasawa, Shunsuke Tatsuki, Yasuko Fukagawa, Hidetoshi Tomabechi, Eriko Takatori, Yoshitaka Kaido, Tadahiro Shoji, Tsukasa Baba
Publikováno v:
Medicina, Vol 57, Iss 6, p 548 (2021)
Background and Objectives: In October 2018, the International Federation of Gynecology and Obstetrics (FIGO) revised its classification of advanced stages of cervical cancer. The main points of the classification are as follows: stage IIIC is newly e
Externí odkaz:
https://doaj.org/article/8fe8762e895a48c08de988beef505bc1
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 2014, Iss 7, Pp 135-137 (2014)
Externí odkaz:
https://doaj.org/article/32058742be234f4393792f7d6d505088
Autor:
MARINA ABE, TADAHIRO SHOJI, YOHEI CHIBA, ERIKO TAKATORI, YOSHITAKA KAIDO, TAKAYUKI NAGASAWA, MASAHIRO KAGABU, FUMIAKI TAKAHASHI, TAKESHI AIDA, TSUKASA BABA
Publikováno v:
Anticancer Research. 43:1265-1272
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa887f181df9584c791482f744822aa3
https://doi.org/10.21873/anticanres.16273
https://doi.org/10.21873/anticanres.16273
Autor:
Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba, Tatsuhiko Shigeto, Yukiko Matsumura, Dai Shimizu, Yukihiro Terada, Manabu Seino, Tsuyoshi Ohta, Satoru Nagase, Shogo Shigeta, Hideki Tokunaga, Muneaki Shimada, Michiko Kaiho-Sakuma, Shigenori Furukawa, Shu Soeda, Takafumi Watanabe, Fumiaki Takahashi, Yoshihito Yokoyama
Publikováno v:
International Journal of Clinical Oncology. 27:1874-1880
Outcomes with and without bevacizumab as first-line chemotherapy in Japanese-only ovarian cancer patients have not been reported. In this study, we report a retrospective study conducted at the Tohoku Gynecologic Cancer Unit.The study included 453 pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e25dc08739652ee1fea35757be57c7f
https://doi.org/10.1007/s10147-022-02246-1
https://doi.org/10.1007/s10147-022-02246-1
Autor:
Terumi Tanigawa, Nobuhiro Takeshima, Hideki Ishikawa, Shin Nishio, Tomoka Usami, Takaharu Yamawaki, Tetsuro Oishi, Kei Ihira, Hisamori Kato, Mayako Goto, Motoaki Saito, Yusuke Taira, Masatoshi Yokoyama, Tadahiro Shoji, Eiji Kondo, Atsushi Mori, Takeshi Yokoi, Naomi Iwasa-Inoue, Yasuyuki Hirashima, Takayuki Nagasawa, Motoki Takenaka, Mikio Mikami, Toru Sugiyama, Takayuki Enomoto
Publikováno v:
Gynecologic Oncology. 165:413-419
This multicenter, open-label, phase II study aimed to evaluate the efficacy and safety of paclitaxel-carboplatin, bevacizumab, and bevacizumab-based maintenance therapy for metastatic, recurrent, and persistent uterine cervical cancer.Patients with m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::014faa3b352669ec6bed8e45b2e7354a
https://doi.org/10.1016/j.ygyno.2022.04.011
https://doi.org/10.1016/j.ygyno.2022.04.011
Autor:
Masahiko Mori, Takayuki Nagasawa, Takayuki Enomoto, Toru Sugiyama, Yuki Inokuchi, Satoru Nagase, Shoji Kamiura, Tetsuro Oishi, Shinichi Komiyama, Tadahiro Shoji, Masakazu Abe, Nobuhiro Takeshima, Aikou Okamoto
Publikováno v:
Cancer Science
We investigated the efficacy and safety of further bevacizumab therapy in patients with platinum‐resistant ovarian cancer whose disease had progressed after bevacizumab plus chemotherapy. In this multicenter, open‐label, phase II trial (JGOG3023)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fe499469ca565c9ddecee43a14cc54e
http://europepmc.org/articles/PMC8748228
http://europepmc.org/articles/PMC8748228